Shares of Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) have received an average rating of “Buy” from the ten ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $138.8889.
A number of equities analysts have issued reports on the company. Wall Street Zen upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Sunday, June 29th. Macquarie reaffirmed an “outperform” rating and set a $133.00 target price on shares of Addus HomeCare in a research report on Tuesday, June 10th. JMP Securities reissued a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research report on Wednesday, July 16th. UBS Group began coverage on shares of Addus HomeCare in a report on Tuesday, September 2nd. They set a “buy” rating and a $145.00 price objective on the stock. Finally, Stephens reissued an “overweight” rating and issued a $140.00 price objective on shares of Addus HomeCare in a research report on Wednesday, September 3rd.
Read Our Latest Stock Report on ADUS
Addus HomeCare Stock Performance
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its quarterly earnings data on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.45 by $0.04. The firm had revenue of $349.44 million for the quarter, compared to analyst estimates of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business’s quarterly revenue was up 21.8% compared to the same quarter last year. During the same period last year, the firm earned $1.35 earnings per share. Sell-side analysts predict that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Addus HomeCare news, Director Veronica Hill-Milbourne sold 1,571 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total value of $180,555.03. Following the sale, the director owned 5,067 shares of the company’s stock, valued at $582,350.31. This trade represents a 23.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the completion of the transaction, the chief executive officer directly owned 166,461 shares of the company’s stock, valued at approximately $19,134,691.95. This represents a 13.06% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,310 shares of company stock valued at $3,958,375. Company insiders own 4.50% of the company’s stock.
Hedge Funds Weigh In On Addus HomeCare
Hedge funds have recently modified their holdings of the company. GAMMA Investing LLC lifted its holdings in Addus HomeCare by 6.3% in the third quarter. GAMMA Investing LLC now owns 1,778 shares of the company’s stock worth $210,000 after buying an additional 105 shares during the period. Thrivent Financial for Lutherans boosted its stake in Addus HomeCare by 1.4% during the 2nd quarter. Thrivent Financial for Lutherans now owns 13,350 shares of the company’s stock valued at $1,538,000 after purchasing an additional 179 shares during the last quarter. State of Wyoming bought a new stake in Addus HomeCare in the 2nd quarter worth about $47,000. Public Sector Pension Investment Board raised its holdings in shares of Addus HomeCare by 9.0% during the second quarter. Public Sector Pension Investment Board now owns 61,934 shares of the company’s stock valued at $7,134,000 after purchasing an additional 5,098 shares during the last quarter. Finally, CANADA LIFE ASSURANCE Co lifted its holdings in shares of Addus HomeCare by 0.6% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock valued at $2,150,000 after buying an additional 106 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories
- Five stocks we like better than Addus HomeCare
- Canadian Penny Stocks: Can They Make You Rich?
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- What is a Microcap Stock? Everything You Need to Know
- NVIDIA Breaks Out to New Highs: What Comes Next?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
